SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-16-015016
Filing Date
2016-05-09
Accepted
2016-05-09 16:39:36
Documents
65
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1601218-10q.htm 10-Q 1103343
2 EXHIBIT 2.1 t1601218_ex2-1.htm EX-2.1 435733
3 EXHIBIT 31.1 t1601218_ex31-1.htm EX-31.1 6711
4 EXHIBIT 31.2 t1601218_ex31-2.htm EX-31.2 6693
5 EXHIBIT 32.1 t1601218_ex32-1.htm EX-32.1 2803
6 EXHIBIT 32.2 t1601218_ex32-2.htm EX-32.2 2783
  Complete submission text file 0001571049-16-015016.txt   4665346

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pahc-20160331.xml EX-101.INS 821193
8 XBRL SCHEMA FILE pahc-20160331.xsd EX-101.SCH 32031
9 XBRL CALCULATION FILE pahc-20160331_cal.xml EX-101.CAL 56344
10 XBRL DEFINITION FILE pahc-20160331_def.xml EX-101.DEF 102723
11 XBRL LABEL FILE pahc-20160331_lab.xml EX-101.LAB 303442
12 XBRL PRESENTATION FILE pahc-20160331_pre.xml EX-101.PRE 211171
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 161632218
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences